Guanylate binding protein 5 (GBP5), an interferon-stimulated gene that is highly up-regulated in IBD, enhances the expression of pro-inflammatory cytokines in mononuclear cells as a result of its ability to promote NLRP3 inflammasome activation through a not yet defined mechanism (43–46). This evidence concerns the gene GBP5 and inflammatory bowel disease.